CVS Health Corporation
CVS
$95.22
$0.310.32%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 2.98B | 2.94B | 2.94B | -3.98B | 1.02B |
| Total Depreciation and Amortization | 1.13B | 1.12B | 1.15B | 1.13B | 1.17B |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 42.00M | 189.00M | 321.00M | 5.21B | 14.00M |
| Change in Net Operating Assets | 2.20B | 2.00M | -1.02B | -1.57B | -309.00M |
| Cash from Operations | 6.35B | 4.25B | 3.39B | 796.00M | 1.90B |
| Capital Expenditure | -691.00M | -849.00M | -784.00M | -698.00M | -607.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -4.00M | -5.00M | -7.00M | -290.00M | -119.00M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.19B | -20.00M | -1.21B | -1.10B | -298.00M |
| Cash from Investing | -1.88B | -874.00M | -2.00B | -2.09B | -1.02B |
| Total Debt Issued | -- | -- | 0.00 | 3.05B | 921.00M |
| Total Debt Repaid | -1.77B | -1.52B | -1.27B | -3.72B | 840.00M |
| Issuance of Common Stock | 114.00M | 103.00M | 86.00M | 117.00M | 47.00M |
| Repurchase of Common Stock | -145.00M | -9.00M | -13.00M | -20.00M | -114.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -878.00M | -847.00M | -845.00M | -846.00M | -866.00M |
| Other Financing Activities | -15.00M | -47.00M | 7.00M | 38.00M | -22.00M |
| Cash from Financing | -2.69B | -2.32B | -2.03B | -1.38B | 806.00M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.77B | 1.06B | -640.00M | -2.67B | 1.68B |